Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Kedudukan dalam Saham
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Harga Saham
$20.91
Modal Pasaran
$7.57B
Perubahan (1 hari)
-8.26%
Perubahan (1 tahun)
41.25%
Negara
CN
Perdagangan Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategori
Healthcare
Nisbah P/S bagi Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Nisbah P/S pada October 2026 TTM: 7.13
Menurut laporan kewangan dan harga saham terkini Asymchem Laboratories (Tianjin) Co., Ltd., nisbah P/S semasa (TTM) ialah 7.13. Pada akhir 2024, nisbah P/S syarikat ialah 4.62.
Sejarah nisbah P/S untuk Asymchem Laboratories (Tianjin) Co., Ltd. dari 2011 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 7.13 | 42.91% |
| 2025 | 4.99 | 7.98% |
| 2024 | 4.62 | -10.70% |
| 2023 | 5.18 | -2.22% |
| 2022 | 5.30 | -76.76% |
| 2021 | 22.78 | 2.56% |
| 2020 | 22.21 | 84.37% |
| 2019 | 12.05 | 44.66% |
| 2018 | 8.33 | -10.99% |
| 2017 | 9.36 | -21.44% |
| 2016 | 11.91 | 150.64% |
| 2015 | 4.75 | -14.04% |
| 2014 | 5.53 | -24.18% |
| 2013 | 7.29 | -21.71% |
| 2012 | 9.31 | -4.01% |
| 2011 | 9.70 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| 10.72 | 50.35% |
US
|
|
| 41.70 | 484.79% |
US
|
|
| 4.19 | -41.23% |
AU
|
|
| 5.80 | -18.73% |
BE
|
|
| 10.44 | 46.45% |
NL
|
